RESUMEN
A six-year-old Brussels griffon was presented for cervical swelling three months after implantation of a transvenous pacemaker. Transthoracic echocardiography demonstrated a thrombus associated with the pacemaker lead, partially obstructing right atrial inflow. The laboratory findings were consistent with protein-losing nephropathy. Initial medical therapy consisted of rivaroxaban (0.68 mg/kg orally every 24 hours), clopidogrel (2.5 mg/kg orally every 24 hours), and enalapril (0.5 mg/kg orally every 12 hours). Resolution of cervical and thoracic edema was noted within two weeks of initiating therapy. Recheck echocardiography two months and one year later revealed decreasing thrombus size despite worsening proteinuria. To the authors' knowledge, this is the first documented use of rivaroxaban for successful medical treatment of cranial vena cava syndrome caused by intracardiac pacemaker lead thrombosis in a hypercoagulable patient.
Asunto(s)
Enfermedades de los Perros/tratamiento farmacológico , Ecocardiografía/veterinaria , Marcapaso Artificial/veterinaria , Rivaroxabán/uso terapéutico , Síndrome de la Vena Cava Superior/veterinaria , Animales , Enfermedades de los Perros/etiología , Perros , Femenino , Marcapaso Artificial/efectos adversos , Síndrome de la Vena Cava Superior/tratamiento farmacológico , Síndrome de la Vena Cava Superior/etiologíaRESUMEN
BACKGROUND: The geriatric wasting syndrome (GWS) has been associated with proinflammatory cytokines, depression and progressive decline in quality of life (QOL). The objective of this study was to evaluate the correlation between the changes in cytokine levels and appetite, nutritional markers, and QOL in geriatric patients with GWS following a randomized clinical trial of megestrol acetate (MA) versus placebo. METHODS: This was a prospective, double-blind, placebo-controlled trial. We evaluated 69 predominantly male (3 females) nursing home residents with weight loss of > or =5% of their usual body weight over the past three months or body weight 20% below their ideal body weight. Patients were randomly assigned to receive either placebo or megestrol acetate (MA) oral suspension (O.S.) 800 mg/day for 12 weeks and were then followed for 13 weeks off treatment. Data on appetite, weight, nutritional status, QOL and cytokine levels were collected at baseline and week 12. The correlation between appetite, weight, nutritional status, sense of well being and cytokine level changes in response to MA treatment was examined at week 12. RESULTS: Appetite, sense of well being, and QOL assessed by an "enjoyment list" significantly improved in the MA arm. Rising prealbumin showed a negative correlation with decreasing IL-6 (r = -0.51), TNFR-p 55 (r = -0.49) and sIL-2R (r = -0.38). There was also an improvement in prealbumin and a decrease in IL-6 and TNFR-p55 in the MA-arm (p < 0.01). A correlation between a decrease in the IL-6 levels and improvement in depression (r = 0.50) was seen in the MA arm as well. Improvement in appetite positively correlated with increased enjoyment of life (r = -0.41), less depression (r = -0.34), improved sense of well being (r = 0.36), prealbumin gain (r = 0.30), and weight gain (r = 0.38) by 12 weeks. Also, improvement in appetite positively correlated with improvement in nutritional parameters such as prealbumin, albumin, fat free mass and weight in the MA arm. CONCLUSIONS: In a geriatric nursing home population with weight loss, reduction in cytokine levels after MA treatment correlates with improvement in appetite, prealbumin, albumin, and improvement in quality of life.
Asunto(s)
Apetito/efectos de los fármacos , Citocinas/efectos de los fármacos , Acetato de Megestrol/uso terapéutico , Estado Nutricional , Calidad de Vida , Síndrome Debilitante/tratamiento farmacológico , Anciano , Citocinas/sangre , Método Doble Ciego , Femenino , Humanos , Masculino , Acetato de Megestrol/farmacología , Casas de Salud , Estudios Prospectivos , Estadística como Asunto , Aumento de Peso/efectos de los fármacosRESUMEN
This cross-sectional study reports associations between anthropometric measures, serum antioxidant concentrations, and present diet with measures of elevated cell proliferation in 51 patients with Barrett's esophagus. Cell proliferation was assessed as fractions of cells in the S and G2 phases, measured in biopsies of Barrett's tissue and analyzed by DNA content flow cytometry. Elevated proportions in the S and G2 phases predict progression to adenocarcinoma. The percentage of cells in the S phase was positively associated with waist-to-hip ratio (r = 0.33, p < 0.05) and negatively associated with serum and dietary selenium (r = -0.34 and -0.32, respectively, p < 0.05). The percentage of cells in the G2 phase was positively associated with weight change from age 25 (r = 0.39, p < 0.01) and negatively associated with dietary selenium (r = -0.31, p < 0.05). Selenium from breads and grains was negatively associated with the percentage of cells in the S phase (r = -0.41, p < 0.01) and the percentage of cells in the G2 phase (r = -0.41, p < 0.01). These results suggest that increasing weight gain in adulthood, increasing waist-to-hip ratio, and decreasing dietary selenium intake and serum levels increase the risk of progression of Barrett's esophagus to adenocarcinoma.
Asunto(s)
Esófago de Barrett/patología , Esófago de Barrett/fisiopatología , Constitución Corporal , Dieta , Selenio/sangre , Aumento de Peso , Adenocarcinoma/etiología , Adenocarcinoma/patología , Anciano , Esófago de Barrett/complicaciones , Biopsia , División Celular , ADN/análisis , Neoplasias Esofágicas/etiología , Neoplasias Esofágicas/patología , Femenino , Citometría de Flujo , Fase G2 , Humanos , Masculino , Persona de Mediana Edad , Fase S , Selenio/administración & dosificaciónRESUMEN
Physical rehabilitation is a valuable and often underutilized part of the overall management of small animals with OA. A team consisting of the veterinarian, physical therapist, veterinary technician, and owner is vital to determine and carry out an appropriate therapeutic regimen. To maintain enthusiasm for the program, measurements should be regularly obtained to document progress. In addition, controlled studies should be performed to determine the degree of improvement that may be expected with physical rehabilitation programs.
Asunto(s)
Enfermedades de los Perros/terapia , Osteoartritis/veterinaria , Condicionamiento Físico Animal , Modalidades de Fisioterapia/métodos , Animales , Crioterapia/métodos , Crioterapia/veterinaria , Diatermia/métodos , Diatermia/veterinaria , Enfermedades de los Perros/fisiopatología , Perros , Terapia por Estimulación Eléctrica/métodos , Terapia por Estimulación Eléctrica/veterinaria , Ambiente , Displasia Pélvica Canina/fisiopatología , Displasia Pélvica Canina/terapia , Calor , Hidroterapia/métodos , Hidroterapia/veterinaria , Masaje/métodos , Masaje/veterinaria , Osteoartritis/rehabilitación , Osteoartritis/terapia , Resultado del TratamientoRESUMEN
BACKGROUND: Evidence from observational epidemiologic studies has indicated that antioxidants consumed through the diet or as dietary supplements lower the risk of developing atherosclerotic cardiovascular disease. Evidence suggesting that the major mechanism for the protective effect of antioxidants is mediated through decreased oxidation of lipids, particularly low-density lipoprotein (LDL) cholesterol is accumulating. Other evidence, however, suggests that antioxidants may influence traditional modifiable cardiovascular risk factors such as the blood pressure and serum lipids favorably. The purpose of this study was to determine the effect of antioxidant vitamin supplementation on modifiable risk factors for atherosclerotic cardiovascular disease. DESIGN: A randomized, placebo-controlled, clinical trial of antioxidant vitamin supplementation, conducted at a single community-based clinical research center. METHODS: We assigned 297 retired teachers who were members of the Maryland Retired Teachers Association randomly to 2-4 months of dietary supplementation with placebo or combined antioxidant vitamin capsules providing 400 IU/day vitamin E, 500 mg/day vitamin C, and 6 mg/day beta-carotene. The outcome measures were the blood pressure, fasting serum total cholesterol, high-density lipoprotein cholesterol, LDL cholesterol, and fasting glucose. RESULTS: After 2-4 months of supplementation the combined antioxidant supplement had had no significant effect on the systolic and diastolic blood pressures, fasting serum lipids (total cholesterol, high-density lipoprotein cholesterol, and LDL cholesterol) and fasting glucose, with unadjusted and adjusted analyses. CONCLUSION: Data from this trial suggest that the protective effect from antioxidant vitamin supplementation, if there is one, likely results from mechanisms other than modification of traditionally modifiable cardiovascular risk factors.
Asunto(s)
Antioxidantes/uso terapéutico , Arteriosclerosis/prevención & control , Ácido Ascórbico/uso terapéutico , Enfermedades Cardiovasculares/prevención & control , Vitamina E/uso terapéutico , beta Caroteno/uso terapéutico , Arteriosclerosis/epidemiología , Glucemia/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Enfermedades Cardiovasculares/epidemiología , Método Doble Ciego , Femenino , Humanos , Lípidos/sangre , Masculino , Persona de Mediana Edad , Proyectos Piloto , Factores de Riesgo , Factores de TiempoRESUMEN
We examined the risk of coronary heart disease (CHD) associated with coffee intake in 1040 male medical students followed for 28 to 44 years. During the follow-up, CHD developed in 111 men. The relative risks (95% confidence interval) associated with drinking 5 cups of coffee/d were 2.94 (1.27, 6.81) for baseline, 5.52 (1.31, 23.18) for average, and 1.95 (0.86, 4.40) for most recent intake after adjustment for baseline age, serum cholesterol levels, calendar time, and the time-dependent covariates number of cigarettes, body mass index, and incident hypertension and diabetes. Risks were elevated in both smokers and nonsmokers and were stronger for myocardial infarction. Most of the excess risk was associated with coffee drinking prior to 1975. The diagnosis of hypertension was associated with a subsequent reduction in coffee intake. Negative results in some studies may be due to the assessment of coffee intake later in life or to differences in methods of coffee preparation between study populations or over calendar time.
Asunto(s)
Café/efectos adversos , Cardiopatías/epidemiología , Adulto , Análisis de Varianza , Presión Sanguínea/efectos de los fármacos , Colesterol/sangre , Café/fisiología , Factores de Confusión Epidemiológicos , Relación Dosis-Respuesta a Droga , Estudios de Seguimiento , Cardiopatías/inducido químicamente , Humanos , Incidencia , Masculino , Modelos de Riesgos Proporcionales , Factores de Riesgo , Fumar , Análisis de SupervivenciaRESUMEN
A randomized, double-blind, placebo-controlled, crossover clinical trial was designed to test the efficacy of psyllium fiber in lowering elevated low-density lipoprotein cholesterol (LDL-C) levels in children 5 to 17 years of age. Subjects with LDL-C levels > 2.84 mmol/L (110 mg/dl) after at least 3 months of a low total fat, low saturated fat, low cholesterol diet were enrolled. Two ready-to-eat cereals, with water-soluble psyllium fiber (6 gm/day) and without, were prescribed for 4 to 5 weeks each, with an intervening 2-week washout phase. Reported compliance rates exceeded 80% in the 20 subjects who completed the study. Mean initial total cholesterol, LDL-C, high-density lipoprotein cholesterol, and triglyceride values were 5.23, 3.60, 1.18, and 2.22 mmol/L, respectively. Comparison of the mean changes (from baseline) in lipid values after the two periods of cereal consumption revealed no statistically nor clinically significant differences in total cholesterol, LDL-C, or high-density lipoprotein cholesterol values. Triglyceride levels, however, increased 0.68 mmol/L (26 mg/dl; p < 0.05) after the control cereal in comparison with the psyllium cereal. No significant differences were noted in the children's dietary intake (assessed by 7-day diet records) during the two study periods. Measures of growth (height, weight, and skin-fold thicknesses), and blood vitamin (folic acid; vitamins A, D, and E) and mineral (iron, zinc, and calcium) levels were not affected. In this study, psyllium fiber had no additional lowering effect on total cholesterol or LDL-C levels in children who were already following low total fat, low saturated fat, low cholesterol diets.
Asunto(s)
Fibras de la Dieta/uso terapéutico , Hipercolesterolemia/dietoterapia , Psyllium/uso terapéutico , Adolescente , Distribución de Chi-Cuadrado , Niño , Preescolar , Colesterol/sangre , LDL-Colesterol/sangre , Intervalos de Confianza , Método Doble Ciego , Ayuno/sangre , Femenino , Humanos , Hipercolesterolemia/sangre , Hipercolesterolemia/epidemiología , Masculino , Factores de TiempoRESUMEN
Thirty-five patients who were to have posterior spinal arthrodesis, total hip arthroplasty, or total knee arthroplasty were entered into one of two groups: Group A, to receive unwashed, filtered sanguineous drainage from the wound, or Group B, to receive washed, filtered drainage. The purpose of this prospective study was to evaluate the safety, efficacy, and difficulty of reinfusion of washed compared with unwashed drainage that had been salvaged from the wound after an orthopaedic operation. The sixteen patients in Group A received a mean of 475 milliliters of unwashed drainage for each total knee arthroplasty, 427 milliliters for each total hip arthroplasty, and ten milliliters for the one posterior spinal arthrodesis. The complications included immediate hypotension (two patients), hyperthermia (one patient), and hypotension five hours after reinfusion (one patient). The latter patient died, four days after the operation, of a massive myocardial infarction. The nineteen patients in Group B received a mean of 193 milliliters of washed, filtered drainage for each total knee arthroplasty, 203 milliliters for each total hip arthroplasty, and 179 milliliters for each posterior spinal arthrodesis. Salvage and reinfusion of washed drainage from the wound caused no problems in these patients.
Asunto(s)
Pérdida de Sangre Quirúrgica , Transfusión de Sangre Autóloga/métodos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Transfusión de Sangre Autóloga/efectos adversos , Niño , Drenaje , Filtración , Hematócrito , Prótesis de Cadera , Humanos , Hipotensión/etiología , Prótesis de la Rodilla , Persona de Mediana Edad , Cuidados Posoperatorios , Estudios Prospectivos , Seguridad , Fusión VertebralRESUMEN
OBJECTIVE: --To determine the effect of filtered-coffee consumption on plasma lipoprotein cholesterol levels in healthy men. DESIGN: --Randomized controlled trial with an 8-week washout period followed by an 8-week intervention period during which men were randomly assigned to drink 720 mL/d of caffeinated coffee, 360 mL/d of caffeinated coffee, 720 mL/d of decaffeinated coffee, or no coffee. SETTING: --Outpatient clinical research center in a university medical center. PARTICIPANTS: --One hundred healthy male volunteers. OUTCOME MEASURE: --Changes in plasma lipoprotein cholesterol levels during the intervention period. RESULTS: --Men who consumed 720 mL of caffeinated coffee daily had mean increases in plasma levels of total cholesterol (0.24 mmol/L, P = .001), low-density lipoprotein cholesterol (0.17 mmol/L, P = .04), and high-density lipoprotein cholesterol (0.08 mmol/L, P = .03). No significant changes in these plasma lipoprotein levels occurred in the other groups. Compared with the group who drank no coffee the group who drank 720 mL/d of caffeinated coffee had increases in plasma levels of total cholesterol (0.25 mmol/L, P = .02), low-density lipoprotein cholesterol (0.15 mmol/L, P = .17), and high-density lipoprotein cholesterol (0.09 mmol/L, P = .12) after adjustment for changes in diet. CONCLUSION: --Consumption of 720 mL/d of filtered, caffeinated coffee leads to a statistically significant increase in the plasma level of total cholesterol, which appears to be due to increases of both low-density lipoprotein and high-density lipoprotein cholesterol levels.
Asunto(s)
Café , Lípidos/sangre , Adulto , Colesterol/sangre , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Filtración , Humanos , Masculino , Persona de Mediana Edad , Triglicéridos/sangreRESUMEN
Repeated administration of low doses of puromycin aminonucleoside (PAMN) to rats induces a proteinuric renal disease that resembles focal segmental glomerulosclerosis (FSGS). Reactive oxygen molecules may be involved in the progressive course of this nephropathy. Therefore we evaluated whether taurine, an endogenous antioxidant, could limit the extent of renal injury. Sprague-Dawley rats received low-dose injections of PAMN, 2 mg/100 g body wt, over a 12-wk period. Two groups were studied: 1) controls given tap water (n = 23), and 2) an experimental group that drank 1% taurine-supplemented water (n = 22). Taurine-treated nephrotic rats had a reduction in albuminuria, as assessed by the urinary albumin-to-creatinine ratio (26 +/- 4 vs. 44 +/- 4, P less than 0.0001). After 12 wk, creatinine clearance was 0.33 +/- 0.03 (experimental) vs. 0.17 +/- 0.03 ml.min-1.100 g body wt-1 (control) (P less than 0.001), and inulin clearance (n = 6 pairs) was 0.26 +/- 0.04 (experimental) vs. 0.13 +/- 0.02 ml.min-1.100 g body wt-1 (control) (P less than 0.025). Administration of taurine reduced the percentage of segmentally sclerosed glomeruli (9.8 +/- 1.7 vs. 16.2 +/- 1.8%, P less than 0.02) and the tubulointerstitial injury score (1.36 +/- 0.19 vs. 2.61 +/- 0.25, P less than 0.0025) in experimental vs. control rats. Taurine treatment normalized the elevated renal cortical malondialdehyde level in rats with PAMN nephropathy (P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Enfermedades Renales/fisiopatología , Puromicina Aminonucleósido , Taurina/farmacología , Animales , Enfermedad Crónica , Creatinina/sangre , Riñón/efectos de los fármacos , Riñón/patología , Riñón/fisiopatología , Enfermedades Renales/inducido químicamente , Enfermedades Renales/patología , Masculino , Proteinuria/inducido químicamente , Ratas , Ratas EndogámicasRESUMEN
The pathogenesis of reflex sympathetic dystrophy is controversial, but the condition can result from a major or seemingly minor injury to a limb, or even an insult to an organ, such as stroke or myocardial infarction. Onset can be sudden or insidious. The syndrome is characterized primarily by localized, deep, burning pain in a limb--pain that may not follow any logical distribution. Nonpitting edema, skin hyperesthesia, and guarding of the limb usually accompany the pain. If treatment is not instituted, deformity, contracture, and wasting of the limb can eventually occur. With appropriate therapy, the process can be stopped and often reversed. The keys are a high index of suspicion, early diagnosis, and aggressive treatment.
Asunto(s)
Distrofia Simpática Refleja/terapia , Protocolos Clínicos , Diagnóstico Diferencial , Educación Médica Continua , Femenino , Humanos , Manipulación Ortopédica , Persona de Mediana Edad , Bloqueo Nervioso , Modalidades de Fisioterapia , Distrofia Simpática Refleja/diagnóstico , Distrofia Simpática Refleja/etiología , Férulas (Fijadores) , Terminología como Asunto , Estimulación Eléctrica Transcutánea del NervioRESUMEN
We describe the normal gross anatomy and histology of the colon, with emphasis on the appearance of the mucosa as seen in the endoscopic biopsies. Various artifacts that may be encountered as a result of trauma from the biopsy forceps, incorrect orientation of the tissue, fixation, and the effects of laxatives and enemas are described and illustrated. Recommendations for optimum handling of biopsies are made.
Asunto(s)
Colon/anatomía & histología , Mucosa Intestinal/ultraestructura , Biopsia/efectos adversos , Catárticos/efectos adversos , Endoscopía , Enema/efectos adversos , Epitelio/ultraestructura , Humanos , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/lesiones , Microscopía Electrónica de Rastreo , Manejo de EspecímenesRESUMEN
We compared intravenously administered ciprofloxacin with ceftazidime in a randomized, double-blind study. Patients received ciprofloxacin 200 mg intravenously every 12 hours or ceftazidime 2 g intravenously every eight hours, with placebo infusions to maintain blinding. Therapy with metronidazole was added for suspected or documented intra-abdominal infection. Thirty-two of the 57 ciprofloxacin-treated patients were evaluable for determination of efficacy and had 41 bacterial isolates from 34 sites. Thirty-six of the 56 ceftazidime patients were evaluable for determination of efficacy and had 41 bacterial isolates from 38 sites. Seven of 35 bacteremic patients had no identifiable primary focus. The most commonly isolated pathogens were Escherichia coli, Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae. Cure rates and bacteriologic eradication rates were comparable. Nine patients did not improve. Patients with treatment failures in the ciprofloxacin group included a quadriplegic patient with relapse of urinary tract infection with bacteremia (K. pneumoniae). Another patient with bacteremia (Pseudomonas aeruginosa), pneumonia (Proteus vulgaris), and urinary tract infection (P. vulgaris, Providencia sp.) died on the first treatment day. The third patient (S. aureus and Streptococcus pneumoniae pneumonia) had a new aspiration pneumonia develop on the third day; the pneumococcus also persisted. Undrained S. pneumoniae empyema caused the fourth ciprofloxacin treatment failure, and the fifth patient had a relapse of S. aureus pneumonia with bacteremia. One ceftazidime-treated patient died of pneumococcal pneumonia on the first day. Another had persistent Staphylococcus epidermidis and Listeria bacteremia despite 48 hours of treatment. Two other patients had pneumonia (S. aureus and P. aeruginosa, respectively) and completed full courses of ceftazidime therapy without improvement. Five patients had pneumococcal bacteremia; four patients were cured: one of two patients in the ciprofloxacin group and three of three patients in the ceftazidime group. Significant increases in the number of platelets (four patients with ciprofloxacin treatment, one patient with ceftazidime treatment) and declines in the number of platelets (one patient with ciprofloxacin treatment, one patient with ceftazidime treatment) were observed. Intravenously administered ciprofloxacin is comparable with ceftazidime and is a safe and effective antibiotic for the treatment of patients with serious infections, including bacteremia.
Asunto(s)
Infecciones Bacterianas/tratamiento farmacológico , Ceftazidima/uso terapéutico , Ciprofloxacina/uso terapéutico , Ceftazidima/administración & dosificación , Ceftazidima/efectos adversos , Ciprofloxacina/administración & dosificación , Ciprofloxacina/efectos adversos , Método Doble Ciego , Femenino , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Distribución AleatoriaRESUMEN
We describe a patient with a deficit in imagery ability, following a left posterior cerebral artery infarction and possible anoxic episode. This deficit was inferred from the patient's performance on several tasks, including one in which normal adults are known to rely on imagery and two that tested imagery nonverbally, allowing us to examine the possibility of a language-imagery disconnection. In addition, we queried the patient on some cognitive capacities related to visual imagery: dreaming, geographical knowledge, and introspection regarding visual and auditory imagery. Hypotheses concerning the critical lesion site and underlying cognitive mechanism of image generation deficits are discussed in relation to this and other recent cases of impaired imagery ability with intact recognition ability, and the relevance of this deficit to the "imagery debate" is discussed.
Asunto(s)
Daño Encefálico Crónico/psicología , Infarto Cerebral/psicología , Hipoxia Encefálica/psicología , Imaginación , Anomia/psicología , Humanos , Masculino , Recuerdo Mental , Persona de Mediana Edad , Pruebas Neuropsicológicas , Desempeño Psicomotor , Semántica , Tomografía Computarizada por Rayos XRESUMEN
A right-handed man suffered a left parieto-occipital cerebral infarction, causing agraphia with Gerstmann's syndrome but without major aphasia, alexia, or apraxia. Oral spelling was superior to written spelling. Experiments were performed involving (1) analysis of errors in writing, (2) tasks of visual imagery, and (3) identifying letters drawn without leaving a visual trace. The results suggest that the agraphia and Gerstmann's syndrome are due to a dissociation of language skills and visuospatial skills caused by a dominant parieto-occipital lesion.
Asunto(s)
Agrafia/psicología , Dominancia Cerebral , Síndrome de Gerstmann/psicología , Pruebas Neuropsicológicas , Percepción Espacial , Percepción Visual , Anciano , Infarto Cerebral/psicología , Humanos , Imaginación , Cinestesia , Masculino , Reconocimiento Visual de Modelos , Desempeño Psicomotor , Medición de la Producción del HablaRESUMEN
Inflammatory polyps occur in association with ulcerative colitis, Crohn's disease, and other inflammatory diseases of the colon. The occurrence of inflammatory polyps following ischemic colitis has not been well documented. A 49-year-old man suffered complications of hypoperfusion, including renal insufficiency, hepatic failure, shock lung, and ischemic colitis following emergent repair of an acute aortic dissection. Although the renal, hepatic, and pulmonary complications resolved, the patient continued to experience intermittent bloody diarrhea more than two years after his initial presentation. Barium enema and colonoscopy revealed numerous pedunculated polyps in the descending and sigmoid colon. Histopathology of the polyps removed by snare electrocautery showed them to be inflammatory polyps. We believe these are the sequelae of chronic ischemic colitis.